Zacks Research Has Weak Outlook for Henry Schein Q1 Earnings

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Analysts at Zacks Research dropped their Q1 2025 earnings per share (EPS) estimates for shares of Henry Schein in a research note issued to investors on Tuesday, March 18th. Zacks Research analyst R. Department now expects that the company will post earnings per share of $1.11 for the quarter, down from their prior forecast of $1.17. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. Zacks Research also issued estimates for Henry Schein's Q2 2025 earnings at $1.21 EPS, Q3 2025 earnings at $1.26 EPS, Q4 2025 earnings at $1.26 EPS, FY2025 earnings at $4.84 EPS, Q1 2026 earnings at $1.32 EPS, Q2 2026 earnings at $1.36 EPS, Q3 2026 earnings at $1.25 EPS, Q4 2026 earnings at $1.39 EPS, FY2026 earnings at $5.31 EPS and FY2027 earnings at $5.74 EPS.

HSIC has been the topic of a number of other reports. Mizuho started coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 price objective on the stock. UBS Group cut their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and upped their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Wells Fargo & Company initiated coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price objective for the company. Finally, Barrington Research restated an "outperform" rating and issued a $90.00 price objective on shares of Henry Schein in a research note on Wednesday, February 26th. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $81.10.

Remove Ads

Henry Schein Stock Up 2.0 %

Shares of NASDAQ:HSIC traded up $1.37 during trading on Thursday, hitting $70.76. The company's stock had a trading volume of 779,046 shares, compared to its average volume of 1,508,756. The company has a market capitalization of $8.79 billion, a PE ratio of 29.12, a P/E/G ratio of 2.13 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein has a fifty-two week low of $63.67 and a fifty-two week high of $82.49. The business has a 50 day moving average price of $74.82 and a two-hundred day moving average price of $72.64.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.66 EPS.

Institutional Investors Weigh In On Henry Schein

A number of institutional investors have recently added to or reduced their stakes in HSIC. Versant Capital Management Inc lifted its holdings in shares of Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after buying an additional 335 shares during the period. Investment Management Corp VA ADV acquired a new stake in Henry Schein in the fourth quarter valued at $32,000. Venturi Wealth Management LLC lifted its holdings in Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock valued at $41,000 after acquiring an additional 569 shares during the period. Quent Capital LLC boosted its position in shares of Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company's stock worth $47,000 after purchasing an additional 323 shares in the last quarter. Finally, Smartleaf Asset Management LLC grew its stake in shares of Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after purchasing an additional 143 shares during the period. Hedge funds and other institutional investors own 96.62% of the company's stock.

Insider Activity at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now directly owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.